Validation of the Turkish Translation of the London Speech Evaluation Scale

Sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization (Other)
Overall Status
Completed
CT.gov ID
NCT04690166
Collaborator
(none)
120
1
5
24.2

Study Details

Study Description

Brief Summary

Purpose of the study is the validation and cultual adaptation of the Turkish translation of the London Speech Evaluation Scale (LSE-T), so that it would be used as an assessment tool for Turkish head and neck cancer patients. There is no validated Turkish version of LSE to measure severity of perceptual speech in head and neck cancer patients.

Condition or Disease Intervention/Treatment Phase
  • Other: The speech records related to the reading document

Detailed Description

The speech function is a multidirectional process that depends on complex neuro-muscular network. The function can be evaluated using instrumental, such as voice analysis computer programmes, scales, or well structured questionnaires. There are many scales for assessment of perceptual speech but there is no validated for head and neck patients. The study will assess the construct validity and adaptation of the Turkish translation of Speech Specific Perceptual Speech Evaluation as known as London Speech Evaluation Scale. The investigators developed the Turkish translation of this scale (LSE-T), according to the cross-cultural adaptation guidelines. Two translators translated the LSE into Turkish and a native English language speaker reverse-translated it into English. The back translation was sent to the original author for proofreading. The LSE scale consisted of 6 parameters and 4 scores related with perceptual speech in head and neck cancer patients.

Study Design

Study Type:
Observational
Actual Enrollment :
120 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Validation and Cultural Adaptation of the Turkish Translation of the London Speech Evaluation Scale
Actual Study Start Date :
Dec 21, 2020
Actual Primary Completion Date :
May 21, 2021
Actual Study Completion Date :
May 21, 2021

Arms and Interventions

Arm Intervention/Treatment
Cancer Patients

In outpatients clinic, the first group consists of 60 head and neck cancer patients who were treated by ours. The participants will given the document consists that "bit, bet, but" words and also a brief part of "Diyet passage" who written by Omer Seyffettin. The speech record of patients who read to document, will evaluated by three judges (otorhinolaryngologist). Three judges will scoring to Turkish translation of London Speech Evaluation Scale (LSE-T), consists of 6 parameters. After the six weeks, the records were scored again as randomisely.

Other: The speech records related to the reading document
The document consists "bit, bet, but" words and Diyet passage. Volunteers will read the document in front of the microphone and also the speech will recorded by a computer.

Healty Control

In outpatients clinic, the control group consists of 60 patients who have not speech and hear impairments. The participants will given the document consists that "bit, bet, but" words and also a brief part of "Diyet passage" who written by Omer Seyffettin. The speech record of patients who read to document, will evaluated by three judges (otorhinolaryngologist). Three judges will scoring to Turkish translation of London Speech Evaluation Scale (LSE-T), consists of 6 parameters. After the six weeks, the records were scored again as randomisely.

Other: The speech records related to the reading document
The document consists "bit, bet, but" words and Diyet passage. Volunteers will read the document in front of the microphone and also the speech will recorded by a computer.

Outcome Measures

Primary Outcome Measures

  1. Validation of the Turkish Translation of London Speech Evaluation Scale [Baseline]

    Turkish Translation of London Speech Evaluation Scale consists of 6 parameters and 4 scores. The minimum score is 0 and maximum score is 24. The lower scores mean a better than high scores.

  2. Validation of the Turkish Translation of London Speech Evaluation Scale [6 weeks]

    Turkish Translation of London Speech Evaluation Scale consists of 6 parameters and 4 scores. The minimum score is 0 and maximum score is 24. The lower scores mean a better than high scores.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Able to speak, read, understand and write in Turkish

  • History of oral, orofarengeal cancer

  • Volunteers who accept the informed consent

Exclusion Criteria:
  • Mental disorders

  • Cognitive limitations

  • Able not to speak, read, understand and write in Turkish

  • Underwent any surgery last six month

  • Permanent tracheostomy, total laryngectomy

  • Pregnancy

  • Out of age 18-70 years old

  • Adults who do not accept the informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Prof Dr Cemil Tascioglu City Hospital Istanbul Turkey 34384

Sponsors and Collaborators

  • Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Investigators

  • Principal Investigator: Ziya Salturk, Asso Prof,MD, Anadolu Medical Center, In Affiliation with Johns Hopkins Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yavuz Atar, Associate Professor, M.D., Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
ClinicalTrials.gov Identifier:
NCT04690166
Other Study ID Numbers:
  • 462
First Posted:
Dec 30, 2020
Last Update Posted:
Jul 29, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yavuz Atar, Associate Professor, M.D., Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 29, 2021